VIVO BIO TECH LTD. (VIVOBIOT) financials

VIVO BIO TECH LTD. (VIVOBIOT) NSE/BSE financials on Fincrux: quarterly results, profit and loss, cash flow, balance sheet, ratios, and shareholding.

Incorporated in 1987, Vivo Bio TechLtd is engaged in service of CRO offeringDrug Development & Discovery Servicesto Pharmaceutical & Biotech Companies[1]

Market Cap: ₹37.3Cr.
Current Price: ₹16.8
ROE: -2.57%
ROCE: 7.72%
Book Value: ₹42.0
Dividend Yield: 0.00%
52W High / Low: ₹39.0/15.5

In Jun 2026, VIVO BIO TECH LTD. (VIVOBIOT) reported sales ₹14.14 Cr and net profit ₹0.18 Cr.

Annual TTM: sales ₹54.30 Cr, net profit ₹-3.13 Cr.

Shareholding: Promoters 30.62% (Jun 2026), Public 69.39% (Jun 2026), No. of Shareholders 21,225% (Jun 2026).

VIVOBIOT quarterly results (₹ Cr.)
Category	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026
Sales	12.04	12.21	12.29	12.42	13.02	13.37	13.77	14.14
Expenses	6.37	6.60	7.15	6.90	7.60	7.87	9.59	9.09
Operating Profit	5.67	5.61	5.14	5.52	5.42	5.50	4.18	5.05
OPM %	47.09%	45.95%	41.82%	44.44%	41.63%	41.14%	30.36%	35.71%
Other Income	4.63	0.01	0.15	0.14	0.13	0.14	0.03	0.06
Interest	2.06	1.84	1.68	1.50	1.47	1.40	1.48	1.24
Depreciation	2.29	2.25	2.25	2.64	2.57	2.66	2.75	3.53
Profit before tax	5.95	1.53	1.36	1.52	1.51	1.58	-0.02	0.34
Tax %	10.59%	41.83%	13.24%	9.21%	42.38%	20.25%	27,050.00%	44.12%
Net Profit	5.31	0.89	1.19	1.37	0.87	1.26	-5.44	0.18
EPS in Rs	3.56	0.55	0.69	0.69	0.39	0.57	-2.45	0.08
Raw PDF	—	—	—	—	—	—	—	—

VIVOBIOT profit and loss (₹ Cr.)
Category	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026	TTM
Sales	55.35	51.78	51.39	51.62	44.88	46.67	52.57	54.30
Expenses	42.87	33.98	35.30	29.80	23.62	25.82	31.29	34.15
Operating Profit	12.48	17.80	16.09	21.82	21.26	20.85	21.28	20.15
OPM %	22.55%	34.38%	31.31%	42.27%	47.37%	44.68%	40.48%	37.11%
Other Income	0.05	0.08	0.09	0.04	0.04	4.80	-0.16	0.36
Interest	3.10	3.67	4.27	7.99	7.95	7.55	5.91	5.59
Depreciation	5.17	5.59	7.44	9.27	9.29	9.02	10.63	11.51
Profit before tax	4.26	8.62	4.47	4.60	4.06	9.08	4.58	3.41
Tax %	-4.46%	34.11%	50.78%	42.83%	37.93%	16.63%	142.36%	—
Net Profit	4.44	5.68	2.20	2.63	2.52	7.57	-1.94	-3.13
EPS in Rs	3.45	4.23	1.54	1.76	1.69	4.41	-0.87	-1.41
Dividend Payout %	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	—

VIVOBIOT balance sheet (₹ Cr.)
Category	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Equity Capital	12.35	12.89	13.42	14.26	14.90	14.90	17.16	22.19
Reserves	14.93	20.15	29.13	32.88	36.97	39.49	61.02	71.03
Borrowings	21.67	22.09	28.73	65.24	60.17	70.83	51.80	63.92
Other Liabilities	6.36	6.29	6.03	7.92	8.77	9.58	11.31	17.72
Total Liabilities	55.31	61.42	77.31	120.30	120.81	134.80	141.29	174.86
Fixed Assets	29.82	31.63	48.69	91.81	85.51	77.01	84.88	119.67
CWIP	0.07	0.15	0.32	0.87	1.90	9.21	12.84	4.81
Investments	0.03	0.04	0.04	0.04	0.04	0.04	0.04	21.95
Other Assets	25.39	29.60	28.26	27.58	33.36	48.54	43.53	28.43
Total Assets	55.31	61.42	77.31	120.30	120.81	134.80	141.29	174.86

VIVOBIOT cash flows (₹ Cr.)
Category	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Cash from Operating Activity	-0.79	7.72	14.10	16.43	14.73	15.83	11.83	36.11
Cash from Investing Activity	-3.53	-7.08	-22.82	-51.11	-4.00	-7.95	-15.84	-59.35
Cash from Financing Activity	0.70	-0.18	8.83	35.04	-11.20	-7.56	3.90	23.34
Net Cash Flow	-3.62	0.46	0.11	0.37	-0.47	0.32	-0.11	0.09
Free Cash Flow	-4.32	0.65	-8.72	-34.68	10.73	7.88	-4.01	-1.33
CFO/OP	-13%	60%	96%	116%	77%	82%	67%	174%

VIVOBIOT shareholding pattern (%)
Category	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026
Promoters	42.08%	38.89%	40.85%	39.07%	35.17%	35.17%	35.43%	30.62%
Public	57.91%	61.12%	59.16%	60.94%	64.84%	64.84%	64.58%	69.39%
No. of Shareholders	19,545	21,167	21,935	21,865	21,647	21,622	21,427	21,225

VIVOBIOT key ratios
Category	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Debtor Days	54.98	69.11	51.39	85.37	87.54	92.47	87.67	81.58
Inventory Days	255.75	451.13	672.29	312.99	429.70	831.44	491.08	365.90
Days Payable	152.08	166.72	70.37	74.02	50.68	100.49	61.78	80.81
Cash Conversion Cycle	158.65	353.52	653.31	324.35	466.56	823.42	516.97	366.67
Working Capital Days	37.66	42.47	37.22	17.97	48.93	73.93	111.53	-22.22
ROCE %	9.55%	14.14%	19.44%	9.52%	11.22%	10.12%	9.42%	7.72%

VIVOBIOTUpdated 28 Sept 2026, 6:51

Vivo Bio Tech Ltd.

VIVOBIOTUpdated 28 Sept 2026, 6:51

Market Cap

₹37.3Cr.

Current Price

₹16.8

High / Low

₹39.0/15.5

ROE-2.57%

ROCE7.72%

Book Value₹42.0

Face Value₹10.0

Dividend Yield0.00%

About

Incorporated in 1987, Vivo Bio TechLtd is engaged in service of CRO offeringDrug Development & Discovery Servicesto Pharmaceutical & Biotech Companies[1]

Quarterly results

Last reported quarters₹ Cr.

Quarter	Sales	Interest	Expenses	Other Income	Depreciation	Profit Before Tax	Tax	Net Profit	EPS (₹)
Jun 2023	11.58	1.95	6.98	0	2.29	0.36	30.56	0.26	0.17
Sep 2023	9.04	2.09	4.26	0	2.3	0.39	35.9	0.25	0.17
Dec 2023	12.71	2.22	6.33	0.03	2.28	1.91	30.89	1.32	0.89
Mar 2024	11.55	1.52	6.22	0.01	2.43	1.39	50.36	0.7	0.47
Jun 2024	10.13	1.92	5.76	0.01	2.23	0.23	26.09	0.18	0.12
Sep 2024	12.04	2.06	6.37	4.63	2.29	5.95	10.59	5.31	3.56
Dec 2024	12.21	1.84	6.6	0.01	2.25	1.53	41.83	0.89	0.55
Mar 2025	12.29	1.68	7.15	0.15	2.25	1.36	13.24	1.19	0.69
Jun 2025	12.42	1.5	6.9	0.14	2.64	1.52	9.21	1.37	0.69
Sep 2025	13.02	1.47	7.6	0.13	2.57	1.51	42.38	0.87	0.39
Dec 2025	13.37	1.4	7.87	0.14	2.66	1.58	20.25	1.26	0.57
Mar 2026	13.77	1.48	9.59	0.03	2.75	-0.02	27050	-5.44	-2.45
Jun 2026	14.14	1.24	9.09	0.06	3.53	0.34	44.12	0.18	0.08

Profit & loss

Annual statement₹ Cr.

Year	Sales	Interest	Expenses	Other Income	Depreciation	Profit Before Tax	Tax	Net Profit	EPS (₹)
Mar 2015	17.79	0.51	14.99	0.95	3.05	0.19	-142.11	0.46	0.49
Mar 2016	28.58	0.47	24.87	0.89	3.35	0.78	-16.67	0.91	0.97
Mar 2017	34.13	1.29	26.5	0.4	3.9	2.84	11.62	2.5	2.67
Mar 2018	47	2.37	36.11	0.13	4.64	4.01	21.95	3.12	3.17
Mar 2019	55.83	2.64	46.32	0.01	5.06	1.82	-23.08	2.25	1.82
Mar 2020	55.35	3.1	42.87	0.05	5.17	4.26	-4.46	4.44	3.45
Mar 2021	51.78	3.67	33.98	0.08	5.59	8.62	34.11	5.68	4.23
Mar 2022	51.39	4.27	35.3	0.09	7.44	4.47	50.78	2.2	1.54
Mar 2023	51.62	7.99	29.8	0.04	9.27	4.6	42.83	2.63	1.76
Mar 2024	44.88	7.95	23.62	0.04	9.29	4.06	37.93	2.52	1.69
Mar 2025	46.67	7.55	25.82	4.8	9.02	9.08	16.63	7.57	4.41
Mar 2026	52.57	5.91	31.29	-0.16	10.63	4.58	142.36	-1.94	-0.87
TTM	54.3	5.59	34.15	0.36	11.51	3.41	—	-3.13	-1.41

Shareholding pattern

As of Jun 2026%

Holder	Share
Promoters	30.62%
Public	69.39%

Shareholding trend

Ownership over time%

Quarter	Promoters	Public
Sep 2023	42.08%	57.91%
Dec 2023	42.08%	57.92%
Mar 2024	42.08%	57.92%
Jun 2024	42.08%	57.92%
Sep 2024	42.08%	57.91%
Dec 2024	38.89%	61.12%
Mar 2025	40.85%	59.16%
Jun 2025	39.07%	60.94%
Sep 2025	35.17%	64.84%
Dec 2025	35.17%	64.84%
Mar 2026	35.43%	64.58%
Jun 2026	30.62%	69.39%

Balance sheet

Assets & liabilities₹ Cr.

Period	Equity Capital	Reserves	Borrowings	Other Liabilities	Total Liabilities	Fixed Assets	CWIP	Investments	Other Assets	Total Assets
Mar 2015	9.35	-0.18	5.69	26.57	41.43	19.57	0.07	0.02	21.77	41.43
Mar 2016	9.35	0.73	16.91	18.68	45.67	23.35	0.04	0.03	22.25	45.67
Mar 2017	9.35	3.25	27.06	11.47	51.13	28.37	2.96	0.03	19.77	51.13
Mar 2018	9.85	9.48	25.11	15.09	59.53	27.47	3.94	0.03	28.09	59.53
Mar 2019	12.35	14.93	21.67	6.36	55.31	29.82	0.07	0.03	25.39	55.31
Mar 2020	12.89	20.15	22.09	6.29	61.42	31.63	0.15	0.04	29.6	61.42
Mar 2021	13.42	29.13	28.73	6.03	77.31	48.69	0.32	0.04	28.26	77.31
Mar 2022	14.26	32.88	65.24	7.92	120.3	91.81	0.87	0.04	27.58	120.3
Mar 2023	14.9	36.97	60.17	8.77	120.81	85.51	1.9	0.04	33.36	120.81
Mar 2024	14.9	39.49	70.83	9.58	134.8	77.01	9.21	0.04	48.54	134.8
Mar 2025	17.16	61.02	51.8	11.31	141.29	84.88	12.84	0.04	43.53	141.29
Mar 2026	22.19	71.03	63.92	17.72	174.86	119.67	4.81	21.95	28.43	174.86

Cash flows

Operating, investing & financing₹ Cr.

Period	Operating	Investing	Financing	Net cash flow
Mar 2015	2.13	-1.92	-0.89	-0.68
Mar 2016	8.73	-7.12	-0.32	1.29
Mar 2017	-5.65	-11.84	6.83	-10.67
Mar 2018	11.11	-4.72	-3.43	2.96
Mar 2019	-0.79	-3.53	0.7	-3.62
Mar 2020	7.72	-7.08	-0.18	0.46
Mar 2021	14.1	-22.82	8.83	0.11
Mar 2022	16.43	-51.11	35.04	0.37
Mar 2023	14.73	-4	-11.2	-0.47
Mar 2024	15.83	-7.95	-7.56	0.32
Mar 2025	11.83	-15.84	3.9	-0.11
Mar 2026	36.11	-59.35	23.34	0.09

Key ratios

Historical financial ratios

Category	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Debtor Days	88.43	48.79	82.03	91.48	54.98	69.11	51.39	85.37	87.54	92.47	87.67	81.58
Inventory Days	557.61	169.23	204.47	289.48	255.75	451.13	672.29	312.99	429.70	831.44	491.08	365.90
Days Payable	814.41	362.93	242.14	304.36	152.08	166.72	70.37	74.02	50.68	100.49	61.78	80.81
Cash Conversion Cycle	-168.38	-144.91	44.36	76.61	158.65	353.52	653.31	324.35	466.56	823.42	516.97	366.67
Working Capital Days	-351.66	-128.73	21.28	-11.88	37.66	42.47	37.22	17.97	48.93	73.93	111.53	-22.22
ROCE %	4.67%	5.97%	12.39%	15.17%	9.55%	14.14%	19.44%	9.52%	11.22%	10.12%	9.42%	7.72%

Frequently asked questions

Quick answers about this company's financials on Fincrux

What is the market cap of VIVO BIO TECH LTD. (VIVOBIOT)?

The reported market capitalisation for VIVO BIO TECH LTD. (VIVOBIOT) is ₹37.3Cr. on Fincrux. Figures may update with market data and filings.

What is the current share price of VIVOBIOT?

The current price shown for VIVO BIO TECH LTD. (VIVOBIOT) on Fincrux is ₹16.8 with a 52-week high/low of ₹39.0/15.5.

What were VIVOBIOT latest quarterly results?

For Jun 2026, VIVO BIO TECH LTD. (VIVOBIOT) reported sales ₹14.14 Cr and net profit ₹0.18 Cr (figures in ₹ crore unless noted).

What are VIVOBIOT annual sales and net profit?

For TTM, VIVO BIO TECH LTD. (VIVOBIOT) shows sales of ₹54.30 Cr and net profit of ₹-3.13 Cr on the Fincrux profit & loss statement.

Who owns VIVO BIO TECH LTD. (VIVOBIOT)?

Latest shareholding for VIVO BIO TECH LTD. (VIVOBIOT) on Fincrux: Promoters 30.62% (Jun 2026), Public 69.39% (Jun 2026), No. of Shareholders 21,225% (Jun 2026).

Where can I find VIVO BIO TECH LTD. (VIVOBIOT) financials?

VIVO BIO TECH LTD. (VIVOBIOT) financials on Fincrux include quarterly results, profit and loss, cash flow, balance sheet, key ratios, and shareholding patterns for NSE/BSE research.

Does Fincrux show VIVOBIOT balance sheet and cash flow?

Yes. The VIVO BIO TECH LTD. (VIVOBIOT) page on Fincrux includes balance sheet, cash flow statements, historical ratios, and ownership trends alongside quarterly and annual results.

Figures in ₹ crore unless noted. Data sourced for research and may lag filings.

Last updated 28 September 2026 at 6:51